Cite
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics
MLA
Georgina Dall, et al. “Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics.” British Journal of Clinical Pharmacology, vol. 83, Feb. 2017, pp. 1580–94. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3aff16c78509adda51abf9b986d817fe&authtype=sso&custid=ns315887.
APA
Georgina Dall, Richard E. Nelson, David Bin-Chia Wu, Mohamed A. Kamal, Carl M. J. Kirkpatrick, Aaron W. C. Kamauu, Craig R Rayner, Kenneth K.C. Lee, Nathorn Chaiyakunapruk, Stephen Toovey, Chayanin Pratoomsoot, Keith Nieforth, David C. M. Kong, Huey Yi Chong, & Patrick F. Smith. (2017). Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics. British Journal of Clinical Pharmacology, 83, 1580–1594.
Chicago
Georgina Dall, Richard E. Nelson, David Bin-Chia Wu, Mohamed A. Kamal, Carl M. J. Kirkpatrick, Aaron W. C. Kamauu, Craig R Rayner, et al. 2017. “Interdisciplinary Pharmacometrics Linking Oseltamivir Pharmacology, Influenza Epidemiology and Health Economics to Inform Antiviral Use in Pandemics.” British Journal of Clinical Pharmacology 83 (February): 1580–94. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........3aff16c78509adda51abf9b986d817fe&authtype=sso&custid=ns315887.